Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonists
摘要:
Systematic SAR optimization of the GPR119 agonist lead 1, derived from an internal HTS campaign, led to compound 29. Compound 29 displays significantly improved in vitro activity and oral exposure, leading to GLP1 elevation in acutely dosed mice and reduced glucose excursion in an OGTT study in rats at doses >= 10 mg/kg. (C) 2014 Elsevier Ltd. All rights reserved.
[EN] FUSED HETEROARYL DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE<br/>[FR] DÉRIVÉ D'HÉTÉROARYLE FUSIONNÉ, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION EN MÉDECINE<br/>[ZH] 稠合杂芳基类衍生物、其制备方法及其在医药上的应用